Additionally, miR-483-3p represses IGF1 and IGF1R, while miR-483-5p targets the downstream kinase MAPK1/ERK2, collectively modulating β-cell survival and glucose-stimulated insulin secretion in experimental diabetes [36,146,147]. This evidence concerns the gene MAPK1 and diabetes mellitus.